Uplifting News from Elysium Health That We All Want to Hear

Everyone deserves the opportunity to live a healthier and happier life. Boosting NAD+ levels can be a way to reach for that goal.

The company co-founded by Dr. Leonard Guarente, known as Elysium Health, has some great news in the form of a new supplement designed to support well-being on a cellular level. The supplement, Basis, is the culmination of more than 25 years of aging research and is clinically proven to increase levels of NAD+.

NAD+ is a coenzyme that is essential for hundreds of cells functions, including turning nutrients into energy, maintaining the health of DNA, and regulating circadian rhythms. But our  levels of NAD+ decline as we age, and that lead to a gradual breakdown of those functions.

Elysium Health works in collaboration with scientists and clinicians from the world’s leading institutions such as Harvard, Yale, and Stanford. These scientists guide the direction of the company and its research.

The results of a clinical trial published in November 2017 in the peer-reviewed journal npj: Aging and Mechanisms of Disease demonstrated that taking Basis daily over the course of several weeks increased and sustained higher levels of NAD+. Taking the daily recommended dose of Basis increased NAD+ levels by an average of 40 percent.

Basis is now available to purchase in individual bottles or as a subscription on Elysium Health’s website. You can simply visit the website and choose the plan that works for you. The most popular level of subscription is the six-month plan for $270 ($45 per month)There’s also a month-to-month plan for $50 per month, and a one-year for $480 ($40 per month).

An individual bottle of Basis costs $60, so the longer plans will obviously save users money. .

Taking Basis may be the easiest thing that you can do for your health today. Check it out via the Elysium Health website and subscribe to a plan  that works for you.

CEO of Seattle Genetics Leading the Search for a Cure

Clay Siegall, the president and CEO of Seattle Genetics who started working in the fight against Cancer, is now working to get a drug that could sure cancer into the hands of those that need it so desperately. Here is that journey.

Clay began at the George Washington University, where he received his doctorate in genetics. He immediately began his career in being the best entrepreneur he could. His efforts paid off when the National Cancer Institute and National Institute of Health helped him begin work on anti-body science.

After that, Bristol-Myers Squibb offered him a position that lasted for six years. His work in the drug-development field has shown many how a company is best run. It is truly an inspiration to anyone that is interested in this field of science. Quoted as saying that: “scientists learn from their mistakes,” Clay goes on to comment that failures are what created the solution in many cases within medical science.

This work is his pride and joy, as anyone would expect it to be for a scientist. He has led to the creation of twelve other drugs that help people everyday. While arguably, price is sometimes the one barrier to many receiving the drugs that they need to find a cure, it all starts with the creation of that drug.

CEO of Seattle Genetics, Clay adds that medical science is just beginning to tap into valuable resources that offer the cure for many diseases that continue to plague our world. People like Clay work hard daily to find those drugs and offer the help that can truly save lives. So it isn’t just about being a CEO of a drug company. It’s about winning the race for the cure against the real problem that has needlessly killed so many over the years.